abnormal reactive hyperemia, p. 611
acute wound, p. 606
approximated, p. 606
bioburden, p. 624
capillary closing pressure, p. 609
chronic wound, p. 606
clean contaminated wound, p. 606
clean wound, p. 606
closed wound, p. 605
colonized wound, p. 606
contaminated wound, p. 606
critical closing pressure, p. 609
debridement, p. 623
dehiscence, p. 608
dermis, p. 604
epidermis, p. 603
eschar, p. 612
evisceration, p. 608
fistula, p. 608
friction, p. 610
full- thickness wound, p. 606
granulation tissue, p. 607
healing ridge, p. 608
602
Hemovac drain, p. 626
incontinence- associated dermatitis
(IAD), p. 611
infected wound, p. 606
infection, p. 608
inflammatory phase, p. 606
Jackson- Pratt (JP) drain, p. 626
maceration, p. 610
maturation phase, p. 607
medical adhesive–related skin injury
(MARSI), p. 605
medical device–related pressure
injury, p. 610
moisture- associated skin damage
(MASD), p. 610
open wound, p. 605
papillary dermis, p. 604
partial- thickness wound, p. 605
Penrose drain, p. 627
pressure injury, p. 609
primary intention, p. 606
proliferative phase, p. 606
rete ridges, p. 604
sanguineous, p. 618
scar tissue, p. 607
secondary intention, p. 606
serosanguineous, p. 618
serous, p. 618
shear, p. 610
sinus tract, p. 612
stage 1 pressure injury, p. 611
stage 2 pressure injury, p. 611
stage 3 pressure injury, p. 611
stage 4 pressure injury, p. 612
stratum corneum, p. 604
stratum germinativum, p. 604
subcutaneous layer, p. 605
superficial wound, p. 605
suspected deep tissue injury, p. 612
sutures, p. 628
tertiary intention, p. 606
tunnel, p. 612
undermining, p. 612
unstageable pressure injury, p. 612
wounds, p. 60